亚博全站手机官网登录|登录入口

Home>News>Latest News
Livzon Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) has been approved for launching!
Time:2020-03-09
Share:
QQ截图20200417213805.jpg

     The Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) launched by Zhuhai Livzon Diagnostics Inc. with approval is only designated for in vitro qualitative detection of IgM / IgG antibody to coronavirus (2019-nCoV) in human serum, plasma and venous whole blood, and is only used as supplementary detection index for suspected case with negative result of 2019-nCoV nucleic acid detection, or used in conjunction with nucleic acid detection for diagnosis of suspected case. Medical institutions use only. It only takes 15 minutes to interpret the result. It supports single detection, and can be operated manually or with automatic equipment.  It also supports separate detection of IgM and IgG, and the two results are non-interference.

10人.jpg

Features

1

Flexible sample: serum, plasma, venous whole blood

2

Simple operation: manual operation

3

Interpretation equipment can be matched to ensure standardization of interpretation

4

Fast: results in 1 ~ 15min

Operating procedures

QQ截图20200417213837.jpg

Interpretation of results

QQ截图20200417213849.jpg